WASHINGTON — 85 members of Congress have signed a joint letter urging the Food and Drug Administration (FDA) to cancel its contract with a biomedical procurement company to purchase “fetal tissue” that will be used to create mice with a human immune system in order to test drug safety and efficacy.
“Unborn children are not commodities to be bought and sold,” the letter reads. “The practice of conducting research using the body parts of children whose lives have been violently ended by abortion is abhorrent.”
As previously reported, the FDA had posted a pre-solicitation notice in June outlining its intentions to contract with Advanced Bioscience Resources to obtain what it called “fetal tissue” for research.
“The government intends to solicit and negotiate directly with Advanced Bioscience Resources (ABR) Inc. and no solicitation will be issued. The objective is to acquire tissue for humanized mice. ABR is the only company that can provide the human fetal tissue needed to continue the ongoing research being led by the FDA,” it read.
“Fresh human tissues are required for implantation into severely immune-compromised mice to create chimeric animals that have a human immune system,” the document explained. “This human immune system allows us to test biological drug products for safety and efficacy. This is necessary because these drug products do not bind non-human species drug targets.”
The FDA’s contract with ABR went into effect on July 25, according to information on the General Services Administration website, and will run for one year.
The remainder of this article is available in its entirety at Christian News